Highlights from EHA 2016 press briefings: Nivolumab, SGN-CD33A and hemophilia
The importance of educating stem cell transplant recipients on tuberculosis and cytomegalovirus
Targeted agents in acute myeloid leukemia in elderly patients
Do gene mutations impact clinical outcome in elderly acute myeloid leukemia (AML) patients?
SPIRIT2 trial on dasatinib for AML - safety and side effect management